BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35332045)

  • 41. Effectiveness of a participatory approach to develop school health interventions in four low resource cities: study protocol of the 'empowering adolescents to lead change using health data' cluster randomised controlled trial.
    Guthold R; Kann L; Bhatti L; Abduvahobov P; Ansong J; Atkinson U; Baltag V; Caffe S; Caixeta R; Diallo CB; Fouad H; Haddad S; Hachri H; Jaggi JA; Joshi P; Karna P; Louazani SA; Mbola Mbassi S; Mehta R; Mudgal Y; Nigg CR; Okely AD; Ondarsuhu D; Ouaourir T; Trhari FZ; Riley LM
    BMJ Open; 2023 Jul; 13(7):e071353. PubMed ID: 37407059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential process improvements to increase coverage of human papillomavirus vaccine in schools - A focus on schools with low vaccine uptake.
    Selvey LA; Roux F; Burns S
    Vaccine; 2020 Mar; 38(14):2971-2977. PubMed ID: 32115296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of numerical information on risk knowledge regarding human papillomavirus (HPV) vaccination among schoolgirls: a randomised controlled trial.
    Steckelberg A; Albrecht M; Kezle A; Kasper J; Mühlhauser I
    Ger Med Sci; 2013; 11():Doc15. PubMed ID: 24198750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two Web-Based and Theory-Based Interventions With and Without Brief Motivational Interviewing in the Promotion of Human Papillomavirus Vaccination Among Chinese Men Who Have Sex With Men: Randomized Controlled Trial.
    Wang Z; Lau JTF; Ip TKM; Yu Y; Fong F; Fang Y; Mo PKH
    J Med Internet Res; 2021 Feb; 23(2):e21465. PubMed ID: 33528372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On surmounting the barriers to HPV vaccination: we can do better.
    Attia AC; Wolf J; Núñez AE
    Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
    [TBL] [Abstract][Full Text] [Related]  

  • 47. School-based lifestyle education involving parents for reducing subjective psychosomatic symptoms in Japanese adolescents: study protocol for a cluster randomised controlled trial.
    Watanabe J; Watanabe M; Yamaoka K; Adachi M; Nemoto A; Tango T
    BMJ Open; 2018 Feb; 8(2):e018938. PubMed ID: 29453300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does electronic consent improve the logistics and uptake of HPV vaccination in adolescent girls? A mixed-methods theory informed evaluation of a pilot intervention.
    Chantler T; Pringle E; Bell S; Cooper R; Edmundson E; Nielsen H; Roberts S; Edelstein M; Mounier-Jack S
    BMJ Open; 2020 Nov; 10(11):e038963. PubMed ID: 33148741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPV and HPV vaccine education intervention: effects on parents, healthcare staff, and school staff.
    Reiter PL; Stubbs B; Panozzo CA; Whitesell D; Brewer NT
    Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2354-61. PubMed ID: 21949110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A stepped-wedge cluster randomized trial designed to improve completion of HPV vaccine series and reduce missed opportunities to vaccinate in rural primary care practices.
    Carney PA; Hatch B; Stock I; Dickinson C; Davis M; Larsen R; Valenzuela S; Marino M; Darden PM; Gunn R; Ferrara L; Fagnan LJ
    Implement Sci; 2019 Mar; 14(1):30. PubMed ID: 30866981
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand.
    Blakely T; Kvizhinadze G; Karvonen T; Pearson AL; Smith M; Wilson N
    Vaccine; 2014 May; 32(22):2645-56. PubMed ID: 24662710
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Can School-Located Vaccination Have a Major Impact on Human Papillomavirus Vaccination Rates in the United States?
    Kempe A; Allison MA; Daley MF
    Acad Pediatr; 2018 Mar; 18(2S):S101-S105. PubMed ID: 29502627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccination against human papilloma virus infection in male adolescents: knowledge, attitudes, and acceptability among parents in Italy.
    Bianco A; Pileggi C; Iozzo F; Nobile CG; Pavia M
    Hum Vaccin Immunother; 2014; 10(9):2536-42. PubMed ID: 25483471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improving HPV vaccine delivery at school-based health centers.
    Oliver K; McCorkell C; Pister I; Majid N; Benkel DH; Zucker JR
    Hum Vaccin Immunother; 2019; 15(7-8):1870-1877. PubMed ID: 30735468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies.
    Watson-Jones D; Baisley K; Ponsiano R; Lemme F; Remes P; Ross D; Kapiga S; Mayaud P; de Sanjosé S; Wight D; Changalucha J; Hayes R
    J Infect Dis; 2012 Sep; 206(5):678-86. PubMed ID: 22711908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
    Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
    Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents.
    Huon JF; Grégoire A; Meireles A; Lefebvre M; Péré M; Coutherut J; Biron C; Raffi F; Briend-Godet V
    PLoS One; 2020; 15(10):e0234693. PubMed ID: 33091021
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
    Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
    Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.